An Open Label Extension, Investigator Initiated Trial to Examine Radiographic Progression , Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis. EASIC (European Ankylosing Spondylitis Infliximab Cohort).
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Infliximab (Primary)
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- Acronyms EASIC
- 25 Mar 2016 Status changed from recruiting to active, no longer recruiting, according to results published.
- 25 Mar 2016 Results of extension study (n=71) of this trial were published in the Clinical and Experimental Rheumatology.
- 31 Mar 2009 New trial record